Use access key #2 to skip to page content.
$3.21 -1.39 (-30.22%)
12/1/2008 4:00 PM

MAP Pharmaceuticals (MAPP)

CAPS Rating:
***

Pharmaceutical Preparations

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

MAPP doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

32 Outperforms
5 Underperforms
 

All-Stars

2 Outperforms
1 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on MAPP are also bullish on:

Members bearish on MAPP are also bearish on:

Ticker Tags

Pharmaceuticals (148), IPO in 2007 (232), Micro Cap (4862)
Suggest a tag

MAP Pharmaceuticals At A Glance

Current Price: $3.21
Last Trade Time: 12/1/2008 4:00 PM
Open: $0.00
Previous Close: $4.60
Daily Range: $3.19 - $4.87
52-Week Range: $1.75 - $17.69
Volume: 17,088
Market Cap: $93.97M
P/E Ratio: 0.16
Compare Our Special Broker Offers!

Stock Trends

MAPP VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for MAPP

More Headlines...

Top Bull Pitch

Recs

0

MAP Pharmaceuticals (MAPP)

Avatar ScotSAK (< 20) Submitted: 10/19/07 2:04 AM

A change in the trend of the RSI and a gradual increase in accummulation would indicate that this one is about to turn back up.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 6 :   1 2 Next »

Recs

0

 (MAPP)

Avatar pjani06 (26.54) Submitted: 4/17/08 1:03 PM : Outperform Start Price: $13.52 MAPP Score: -36.59

Speculative play on small biotech company with high insider ownership

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MAPP)

Avatar boater9384 (< 20) Submitted: 4/02/08 9:08 PM : Outperform Start Price: $14.19 MAPP Score: -37.75

Soros holding, good drug trials, nice potential - may not pay out but a good CAPS speculative play.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MAPP)

Avatar ZeroSignal (57.14) Submitted: 4/01/08 5:59 AM : Outperform Start Price: $14.00 MAPP Score: -38.49

1. Two drugs in phase three trials, both with promising clinical results


2. Lots of cash on hand


3. George Soros is one of their largest investors; he was wrong on CountryWide, but the man has been Buffet-like on almost everything else


Long on MAPP


Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MAPP)

Avatar JInvestments (40.08) Submitted: 3/30/08 10:27 PM : Outperform Start Price: $13.31 MAPP Score: -38.42

Stage 3

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MAPP)

Avatar mmulline (< 20) Submitted: 2/24/08 1:49 PM : Outperform Start Price: $13.23 MAPP Score: -36.32

soros

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 6 :   1 2 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLadenburg 44.01 07/28/08 Outperform NS $9.32-65.56%-34.51%-31.05
TrackSoros < 20 10/11/07 Outperform 3W $14.50-77.86%-47.19%-30.68 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links